American Century ETF Trust has released its latest financial report, revealing substantial figures for its Avantis International Small Cap Value ETF. The report, filed on October 30, 2026, shows total assets amounting to approximately $20.74 billion, with net assets of about $20.5 billion. This indicates a strong financial standing for the investment management firm.
The filing details a total liability of around $239.85 million, suggesting effective management of its financial obligations. The report also highlights the ETF's performance, with recent monthly returns indicating a mix of gains and losses.
Background
American Century ETF Trust, incorporated in Delaware, operates within the investment management sector. The firm specializes in managing exchange-traded funds (ETFs), providing investors with diversified investment options. The company is known for its focus on long-term investment strategies, aiming to deliver strong returns for its clients.
What the Filing Says
The filing, identified by accession number 0001193125-26-439162, provides key insights into the performance of the Avantis International Small Cap Value ETF. It notes, "Total assets were reported at $20,739,812,377, with total liabilities of $239,846,747, resulting in net assets of $20,499,965,629." This data reflects the ETF's strong position in the market.
Impact
The financial data disclosed in this filing may impact various stakeholders, including investors, analysts, and competitors. Investors may view the strong asset figures as a positive indicator of the ETF's performance, while analysts will likely assess the implications for the broader investment management industry. Competitors, including firms like Goldman Sachs and Morgan Stanley, may also take note of American Century's performance as they strategize for their own ETF offerings.
What's Next
The filing does not specify what happens next for American Century ETF Trust. However, the continued monitoring of its ETF performance and potential future filings will be essential for stakeholders interested in the firm's ongoing developments.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






